bioAffinity Technologies (BIAF) Profit After Tax (2021 - 2026)
bioAffinity Technologies has reported Profit After Tax over the past 5 years, most recently at -$3.6 million for Q1 2026.
- Quarterly Profit After Tax fell 36.47% to -$3.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$15.9 million through Mar 2026, down 63.06% year-over-year, with the annual reading at -$14.9 million for FY2025, 64.93% down from the prior year.
- Profit After Tax was -$3.6 million for Q1 2026 at bioAffinity Technologies, down from -$3.1 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$88052.0 in Q2 2022 and troughed at -$5.1 million in Q3 2025.
- The 5-year median for Profit After Tax is -$2.3 million (2023), against an average of -$2.6 million.
- The largest YoY upside for Profit After Tax was 53.43% in 2023 against a maximum downside of 1876.3% in 2023.
- A 5-year view of Profit After Tax shows it stood at -$1.7 million in 2022, then crashed by 41.72% to -$2.4 million in 2023, then fell by 25.02% to -$3.0 million in 2024, then fell by 5.75% to -$3.1 million in 2025, then decreased by 15.72% to -$3.6 million in 2026.
- Per Business Quant, the three most recent readings for BIAF's Profit After Tax are -$3.6 million (Q1 2026), -$3.1 million (Q4 2025), and -$5.1 million (Q3 2025).